About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Enrolling By Invitation

Cardiovascular and Cognitive Implications of Central Disorders of Hypersomnolence and Their Treatments

NCT05371483•Mayo Clinic

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

NarcolepsyIdiopathic Hypersomnia

Interventions

24-hour Ambulatory Blood Pressure Monitoring

Oculo-Cognitive Addition Test (OCAT)

Locations

1

United States

Locations (1)

Mayo Clinic Arizona

Scottsdale, Arizona, United States

Key Dates

Start Date

May 18, 2022

Primary Completion Date

May 1, 2026

Completion Date

July 1, 2026

Last Updated

June 29, 2025

Related Studies

RECRUITINGPhase 3

A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy

NCT07363720

Narcolepsy Type 1 (NT1)Narcolepsy With Cataplexy

RECRUITINGPhase 2/3

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

NCT05816382

Narcolepsy Type 1

RECRUITINGPhase 2

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

NCT06952699

Narcolepsy Type 2

RECRUITINGPhase 2

Extended-release Sodium Oxybate in Children

NCT06809803

Narcolepsy Type 1 (NT 1)

Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions

NCT06457945

Narcolepsy Type 1Hypersomnolence+1 more

Study of Psychological, Sociological and Professional Factors Associated With Maintenance of Wakefulness Test

NCT06586138

NarcolepsyObstructive Sleep Apnea (OSA)

View all related studies

Sponsors

Lead Sponsor

Mayo Clinic

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 29, 2025Data synced to Clareo: April 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions